237 related articles for article (PubMed ID: 31103551)
21. Continuous selective intra-arterial application of nimodipine in refractory cerebral vasospasm due to aneurysmal subarachnoid hemorrhage.
Ott S; Jedlicka S; Wolf S; Peter M; Pudenz C; Merker P; Schürer L; Lumenta CB
Biomed Res Int; 2014; 2014():970741. PubMed ID: 24527461
[TBL] [Abstract][Full Text] [Related]
22. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study.
Schmid-Elsaesser R; Kunz M; Zausinger S; Prueckner S; Briegel J; Steiger HJ
Neurosurgery; 2006 Jun; 58(6):1054-65; discussion 1054-65. PubMed ID: 16723884
[TBL] [Abstract][Full Text] [Related]
23. Meta-analysis of the effectiveness and safety of prophylactic use of nimodipine in patients with an aneurysmal subarachnoid haemorrhage.
Liu GJ; Luo J; Zhang LP; Wang ZJ; Xu LL; He GH; Zeng YJ; Wang YF
CNS Neurol Disord Drug Targets; 2011 Nov; 10(7):834-44. PubMed ID: 21999736
[TBL] [Abstract][Full Text] [Related]
24. The Impact of Nimodipine Administration through Feeding Tube on Outcomes in Patients with Aneurysmal Subarachnoid Hemorrhage.
Isse FA; Abdallah YEH; Mahmoud SH
J Pharm Pharm Sci; 2020; 23(1):100-108. PubMed ID: 32348716
[TBL] [Abstract][Full Text] [Related]
25. Hypoxemia associated with nimodipine in a patient with an aneurysmal subarachnoid hemorrhage.
Baker M; Bastin MT; Cook AM; Fraser J; Hessel E
Am J Health Syst Pharm; 2015 Jan; 72(1):39-43. PubMed ID: 25511836
[TBL] [Abstract][Full Text] [Related]
26. Does Nimodipine Interruption due to High Catecholamine Doses Lead to a Greater Incidence of Delayed Cerebral Ischemia in the Setting of Aneurysmal Subarachnoid Hemorrhage?
Hernández-Durán S; Mielke D; Rohde V; Malinova V
World Neurosurg; 2019 Dec; 132():e834-e840. PubMed ID: 31404696
[TBL] [Abstract][Full Text] [Related]
27. NEWTON-2 Cisternal (Nimodipine Microparticles to Enhance Recovery While Reducing Toxicity After Subarachnoid Hemorrhage): A Phase 2, Multicenter, Randomized, Open-Label Safety Study of Intracisternal EG-1962 in Aneurysmal Subarachnoid Hemorrhage.
Macdonald RL; Hänggi D; Ko NU; Darsaut TE; Carlson AP; Wong GK; Etminan N; Mayer SA; Aldrich EF; Diringer MN; Ng D; Strange P; Bleck T; Grubb R; Suarez JI
Neurosurgery; 2020 Dec; 88(1):E13-E26. PubMed ID: 32985652
[TBL] [Abstract][Full Text] [Related]
28. The efficacy of an abbreviated course of nimodipine in patients with good-grade aneurysmal subarachnoid hemorrhage.
Toyota BD
J Neurosurg; 1999 Feb; 90(2):203-6. PubMed ID: 9950489
[TBL] [Abstract][Full Text] [Related]
29. Continuous intra-arterial nimodipine infusion in patients with severe refractory cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a feasibility study and outcome results.
Bele S; Proescholdt MA; Hochreiter A; Schuierer G; Scheitzach J; Wendl C; Kieninger M; Schneiker A; Bründl E; Schödel P; Schebesch KM; Brawanski A
Acta Neurochir (Wien); 2015 Dec; 157(12):2041-50. PubMed ID: 26439105
[TBL] [Abstract][Full Text] [Related]
30. Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial.
Pickard JD; Murray GD; Illingworth R; Shaw MD; Teasdale GM; Foy PM; Humphrey PR; Lang DA; Nelson R; Richards P
BMJ; 1989 Mar; 298(6674):636-42. PubMed ID: 2496789
[TBL] [Abstract][Full Text] [Related]
31. Effect of Intra-Arterial and Intravenous Nimodipine Therapy of Cerebral Vasospasm After Subarachnoid Hemorrhage on Cerebrovascular Reactivity and Oxygenation.
Hockel K; Diedler J; Steiner J; Birkenhauer U; Ernemann U; Schuhmann MU
World Neurosurg; 2017 May; 101():372-378. PubMed ID: 28232152
[TBL] [Abstract][Full Text] [Related]
32. The effect of nimodipine monotherapy and combined treatment with ketamine and lignocaine in aneurysmal subarachnoid haemorrhage.
Langelaar G; Leeuwenkamp OR; Sterkman LG; Torreman M; Hesselink JM
J Int Med Res; 1996; 24(5):425-32. PubMed ID: 8895046
[TBL] [Abstract][Full Text] [Related]
33. Effects of dose-response of topical administration of nimodipine on cerebral vasospasm after subarachnoid hemorrhage in rabbits.
Yin YH; Wang F; Pan YH; Wang Y; Wang Y; Luo QZ; Jiang JY
Am J Med Sci; 2009 Feb; 337(2):123-5. PubMed ID: 19214028
[TBL] [Abstract][Full Text] [Related]
34. Nimodipine treatment of subarachnoid hemorrhage.
Laursen J; Jensen F; Mikkelsen E; Jakobsen P
Clin Neurol Neurosurg; 1988; 90(4):329-37. PubMed ID: 3233859
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of fasudil in patients with subarachnoid hemorrhage: final results of a randomized trial of fasudil versus nimodipine.
Zhao J; Zhou D; Guo J; Ren Z; Zhou L; Wang S; Zhang Y; Xu B; Zhao K; Wang R; Mao Y; Xu B; Zhang X;
Neurol Med Chir (Tokyo); 2011; 51(10):679-83. PubMed ID: 22027241
[TBL] [Abstract][Full Text] [Related]
36. Nimodipine in Clinical Practice: A Pharmacological Update.
Clough B; Tenii J; Wee C; Gunter E; Griffin T; Aiyagari V
J Neurosci Nurs; 2022 Feb; 54(1):19-22. PubMed ID: 34775392
[TBL] [Abstract][Full Text] [Related]
37. Calcium antagonists for aneurysmal subarachnoid haemorrhage.
Rinkel GJ; Feigin VL; Algra A; Vermeulen M; van Gijn J
Cochrane Database Syst Rev; 2002; (4):CD000277. PubMed ID: 12519539
[TBL] [Abstract][Full Text] [Related]
38. Nimodipine in aneurysmal subarachnoid hemorrhage: a randomized study of intravenous or peroral administration.
Kronvall E; Undrén P; Romner B; Säveland H; Cronqvist M; Nilsson OG
J Neurosurg; 2009 Jan; 110(1):58-63. PubMed ID: 18847340
[TBL] [Abstract][Full Text] [Related]
39. Nimodipine prophylaxis in aneurysmal subarachnoid hemorrhage, a question of tradition or evidence: A scoping review.
Bellapart J; Laupland KB; Malacova E; Roberts JA; Paratz J
J Clin Neurosci; 2024 May; 123():91-99. PubMed ID: 38564967
[TBL] [Abstract][Full Text] [Related]
40. Nimodipine-induced acute hypoxemia: case report.
Devlin JW; Coplin WM; Murry KR; Rengachary SS; Wilson RF
Neurosurgery; 2000 Nov; 47(5):1243-6; discussion 1246-7. PubMed ID: 11063120
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
